Analyst Price Targets — CATX
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| March 17, 2026 12:35 pm | Greg Renza | Truist Financial | $12.00 | $5.09 | StreetInsider | Truist Reiterates Buy Rating on Perspective Therapeutics Inc (CATX) |
| February 19, 2026 10:11 am | Biren Amin | Piper Sandler | $16.00 | $5.03 | TheFly | Perspective Therapeutics initiated with an Overweight at Piper Sandler |
| January 30, 2026 11:08 am | — | H.C. Wainwright | $12.00 | $4.26 | TheFly | Perspective Therapeutics price target raised to $12 from $10 at H.C. Wainwright |
| November 21, 2025 12:26 am | David Lai | UBS | $7.00 | $2.12 | TheFly | Perspective Therapeutics price target lowered to $7 from $18 at UBS |
| October 10, 2025 10:59 am | Jeet Mukherjee | BTIG | $14.00 | $4.20 | TheFly | Perspective Therapeutics initiated with a Buy at BTIG |
| October 24, 2024 3:50 am | David Dai | UBS | $20.00 | $11.69 | StreetInsider | UBS Starts Perspective Therapeutics Inc (CATX) at Buy |
| October 14, 2024 6:07 am | Jeff Jones | Oppenheimer | $22.00 | $12.66 | StreetInsider | Oppenheimer Reiterates Outperform Rating on Perspective Therapeutics Inc (CATX) |
| September 25, 2024 6:10 am | Nicole Germino | Truist Financial | $21.00 | $12.28 | StreetInsider | Truist Securities Starts Perspective Therapeutics Inc (CATX) at Buy |
| July 25, 2024 6:11 am | Alec Stranahan | Bank of America Securities | $24.00 | $12.82 | TheFly | Perspective Therapeutics initiated with a Buy at BofA |
| June 18, 2024 7:26 am | Jeff Jones | Oppenheimer | $19.00 | $11.93 | StreetInsider | Perspective Therapeutics Inc (CATX) PT Raised to $19 at Oppenheimer |
Latest News for CATX
Perspective Therapeutics (CATX) is advancing radiopharmaceutical therapies, with a pivotal data readouts expected in 2026 in NETs, plus melanoma / solid tumor data. CATX's VMT-α-NET shows promising early efficacy in SSTR2-positive neuroendocrine tumors, with 76% of patients alive and progression-free in a 25-patient study. Sanofi's discontinuation of Alphamedix and promising comparison withy Novartis' Lutathera…
SEATTLE, April 24, 2026 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering advanced treatments for cancers throughout the body, today announced that it will provide several corporate updates in May 2026. Webcasts of these events, unless noted as press release only, will be posted on the Company's website at…
SEATTLE, April 20, 2026 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or the “Company) (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering advanced treatments for cancers throughout the body, today announced updated interim results from its ongoing Phase 1/2a clinical trial of [212Pb]VMT-α-NET in patients with unresectable or metastatic somatostatin receptor type 2 (SSTR2)…
SEATTLE, April 02, 2026 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering advanced treatments for cancers throughout the body, today announced that members of its senior leadership team will participate in and be available for one-on-one meetings with investors at the following upcoming conferences:
SEATTLE, March 17, 2026 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering advanced treatments for cancers throughout the body, today announced that updated data on the Company's [212Pb]VMT-α-NET program have been accepted as a poster presentation at the American Association for Cancer Research (AACR) Annual…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for CATX.
U.S. House Trading
No House trades found for CATX.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.